1,4-Cyclohexanedicarboxylic Acid (CAS 1076-97-7) Ultimate Guide 2025
Contents
- Product Specifications & Comparative Analysis
- Industrial Applications & Functional Advantages
- Implementation Case Studies
- Client Success Stories
- Technical Consultation & Sample Request
Product Specifications & Comparative Analysis
| Parameter | 1,4-CHDA (CAS 1076-97-7) | Alternative Cyclohexane Derivatives |
|---|---|---|
| Molecular Formula | C8H10O4 | C7H10O4 (1,3-isomer) |
| Purity Grade | ≥99.5% (Industrial Grade) | 98.0-99.0% |
| Thermal Stability | Decomposition at 280°C | 240-260°C |
| Solubility | 20g/L in DMF (25°C) | 15g/L in DMF |
Industrial Applications & Functional Advantages
Primary Applications:
- High-performance polyester resin synthesis
- UV-resistant coating formulations
- Pharmaceutical intermediate for antispasmodics
- Epoxy curing agent production
Performance Advantages:
- Enhances polymer crystallinity by 18-22%
- Improves coating hardness (3H-4H pencil hardness)
- Reduces yellowing index under UV exposure
Implementation Case Studies
Case 1: Automotive Coatings
XYZ Coatings achieved 40% improvement in scratch resistance using 1,4-CHDA modified polyols.
Case 2: Biodegradable Plastics
ABC Polymers developed PBS alternatives with 25% faster decomposition rates.
Client Success Stories
Client A: European Chemical Giant
Challenge: Needed low-VOC polyols for REACH compliance
Solution: 1,4-CHDA-based formulation reduced VOC emissions by 62%
Result: Achieved EU Ecolabel certification within 8 months
Client B: Asian Pharma Leader
Challenge: Required high-purity intermediates for GMP production
Solution: Custom purification process achieving 99.97% purity
Result: Increased API yield by 15% with reduced impurities
Technical Consultation & Sample Request
Contact our technical team for:
- Custom synthesis protocols
- Material compatibility testing
- Regulatory compliance support
Email: info@vivalr.com
Tel: (86) 15866781826
Market Insight: Global demand projected to grow at 6.8% CAGR through 2030 (Source: IndustryARC 2025)



评论
目前还没有评论。